Yichen Liu Selected Research

Yichen Liu Research Topics

Disease

16	Neoplasms (Cancer) 02/2022 - 11/2009
8	Breast Neoplasms (Breast Cancer) 08/2022 - 01/2015
5	Neoplasm Metastasis (Metastasis) 02/2022 - 01/2015
4	Infections 08/2019 - 11/2005
2	Stomach Neoplasms (Stomach Cancer) 02/2022 - 01/2019
2	Hypoxia (Hypoxemia) 01/2022 - 09/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020 - 01/2018
1	Hemophilia A (Haemophilia) 05/2022
1	Atherosclerosis 05/2022
1	Hemorrhage 05/2022
1	Thrombosis (Thrombus) 05/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Male Infertility (Male Sterility) 01/2022
1	Carcinogenesis 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Bone Resorption 01/2022
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021
1	Breast Ductal Carcinoma 01/2021
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 12/2020
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2020
1	Atrial Fibrillation 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 05/2019
1	Glioma (Gliomas) 04/2019
1	Brain Neoplasms (Brain Tumor) 04/2019
1	Adenocarcinoma 01/2019
1	Esophageal Neoplasms (Esophageal Cancer) 01/2019
1	Esophageal Squamous Cell Carcinoma 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Cognitive Dysfunction 01/2018

Drug/Important Bio-Agent (IBA)

6	sinoporphyrin sodiumIBA 08/2022 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2013
3	Pharmaceutical PreparationsIBA 12/2020 - 01/2018
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 07/2016 - 01/2015
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2022
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022 - 11/2020
2	CytokinesIBA 01/2022 - 05/2019
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	hypocrellin BIBA 11/2020 - 01/2019
2	Messenger RNA (mRNA)IBA 03/2009 - 11/2005
1	FibrinIBA 05/2022
1	Factor VIII (Coagulation Factor VIII)IBA 05/2022
1	Sorafenib (BAY 43-9006)FDA Link 02/2022
1	tanshinoneIBA 02/2022
1	erastinIBA 02/2022
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 02/2022
1	Lipid PeroxidesIBA 02/2022
1	Glutathione (Reduced Glutathione)IBA 02/2022
1	SolutionsIBA 01/2022
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Circular RNAIBA 01/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022
1	CateninsIBA 01/2022
1	OsteoprotegerinIBA 01/2022
1	OvalbuminIBA 01/2022
1	HET0016IBA 01/2021
1	Ferritins (Ferritin)IBA 01/2021
1	IronIBA 01/2021
1	Colchicine FDA LinkGeneric 12/2020
1	TubulinIBA 12/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2020
1	Biological ProductsIBA 11/2020
1	RNA (Ribonucleic Acid)IBA 11/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2020
1	LipidsIBA 01/2020
1	Complement System Proteins (Complement)IBA 08/2019
1	huachansuIBA 05/2019
1	EmulsionsIBA 05/2019
1	Adenosine Triphosphate (ATP)IBA 05/2019
1	Saline SolutionIBA 05/2019
1	BufanolidesIBA 05/2019
1	cryptotanshinoneIBA 01/2019
1	PorphyrinsIBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	Janus Kinase 2IBA 01/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	Adenosine Monophosphate (AMP)IBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 11/2016
1	CurcuminIBA 11/2016
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2016
1	Hematoxylin (Haematoxylon)IBA 07/2016
1	Therapeutic UsesIBA 07/2016
1	InsecticidesIBA 01/2015
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2015
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2015
1	NeuroglobinIBA 01/2015

Therapy/Procedure

10	Therapeutics 11/2021 - 11/2009
4	Photochemotherapy (Photodynamic Therapy) 01/2021 - 01/2015
3	Precision Medicine 11/2021 - 01/2015
2	Drug Therapy (Chemotherapy) 05/2019 - 01/2018
1	Lasers (Laser) 05/2022
1	Intraperitoneal Injections 01/2022
1	Oral Administration 12/2020
1	Microbubbles 11/2016